Targeted inhibition of HER-2 positive breast cancer cells by trastuzumab functionalized pullulan-doxorubicin nanoparticles

Human epidermal growth factor receptor-2 (HER-2) positive breast cancer is highly invasive with poor clinical outcomes and high risk of recurrence. Here, trastuzumab functionalized pullulan-doxorubicin nanoparticles (Tz-P-Dox) were developed and characterized as a new anticancer formulation for acti...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Ruiling Xu, Junhui Sui, Mingda Zhao, Yuedi Yang, Lei Tong, Yongmei Liu, Yong Sun, Yujiang Fan, Jie Liang, Xingdong Zhang
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2022-09-01
סדרה:	Polymer Testing
נושאים:	HER-2 overexpression Breast cancer Trastuzumab Pullulan-doxorubicin nanoparticles Targeted inhibition
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S0142941822001921
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!